Description

Breast cancer is the second most common cancer in the world overall, and the most common cancer in women. When diagnosed at a very early stage, the prognosis is positive, with a five-year survival rate of nearly 90%. However, in the later stages of the disease, the survival rate rapidly decreases. HER2-positive breast cancer is an aggressive disease, and historically has had a worse overall survival (OS) than HER2-negative disease, which is considered less aggressive. The current marketed drug landscape in breast cancer includes a mix of targeted therapies, chemotherapies, and hormonal agents. Metastatic breast cancer is not considered a curable disease, and in the course of therapy patients can receive up to three lines of endocrine agents and four or more lines of chemotherapy, as well as targeted therapies for earlier lines of therapy – often in no particular sequence. Hormone therapy is the mainstay of treatment for patients with HR-positive disease, but triple-negative breast cancer (TNBC) patients who lack HR expression are normally treated with generic chemotherapies. This is because there are no approved targeted therapies currently available in the TNBC setting. The HER2-positive breast cancer market is dominated by the HER2-targeting mAb Herceptin, the most established drug in this disease area. Herceptin is used in nearly all settings of HER2-positive breast cancer and in all markets accessed in this report, as it was demonstrated to significantly improve the OS of women with this disease type. The current breast cancer pipeline is demonstrative of strong innovation in cancer overall, and a significant number of new drug launches are expected during the forecast period. This is likely to have a significant impact on the competitive landscape, particularly in the early lines of metastatic disease. The emergence of novel biomarkers will also impact treatment decisions for TNBC patients, and will provide new options for targeted therapy in this patient population, fulfilling a long-standing unmet need. One of the key drivers of the breast cancer therapeutics market in the APAC region is the increase in patient volume. It is also expected to be driven by the anticipated approval of promising therapies within several distinct patient segments, as well as the growing market uptake of already approved therapies in the APAC markets. Although several branded drugs are expected to go off patent during the forecast period, the impact of this on the market will be offset by the launch of upcoming therapies such as Verzenio, Lynparza, Nerlynx, talazoparib, alpelisib, taselisib, Keytruda, Tecentriq, margetuximab and ipatasertib, and the increasing uptake of already approved therapy such as Ibrance, Kadcyla, Perjeta and Kisqali.

Scope

The breast cancer Asia-Pacific market will be valued at $4.75 billion in 2024, growing from $2.16 billion in 2017 at a compound annual growth rate (CAGR) of 11.9%.

How will immune checkpoint inhibitors such as Keytruda and Tecentriq, PARP inhibitors such as Lynparza and talazoparib, and PI3K inhibitors such as taselisib and alpelisib contribute to growth?

What effect will the patent expirations of branded therapies have on market value?

The breast cancer pipeline is large and diverse, with a strong presence of mAbs and targeted therapies.

What are the common targets and mechanisms of action of pipeline therapies?

Will the pipeline address unmet needs such as the lack of targeted therapies available for TNBC patients?

What implications will the increased focus on targeted therapies have on the future of breast cancer treatment?

Numerous late-stage pipeline therapies with a strong clinical record have the potential to enter the market over the forecast period.

How have the late-stage therapies performed in clinical trials?

How would the approval of Keytruda, Tecentriq, Lynparza, talazoparib and ipatasertib to treat TNBC patients affect the competitive landscape, with no targeted therapy currently available to address this patient subset?

The market forecasts indicate that Japan will contribute the most to the Asia-Pacific market value due to the emergence of novel therapies.

How will the annual cost of therapy and market size vary between the five assessed Asia-Pacific markets?

How could changes in risk factors such as population age, early menstruation, late menopause, obesity, smoking, lack of breast-feeding and alcohol consumption influence the market?

Licensing deals are the most common form of strategic alliance in breast cancer, with total deal values ranging from under $10m to over $1 billion.

How do deal frequency and value compare between target families and molecule types?

What were the terms and conditions of key licensing deals?

Reasons To Buy

This report will enable you to:

Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis, and the treatment options available at each stage of diagnosis, including a clinical comparison of marketed therapies.

Visualize the composition of the breast cancer market in terms of the dominant therapies for each patient subset, along with their clinical and commercial standing. Unmet needs are highlighted to allow a competitive understanding of gaps in the market.

Understand the potential of late-stage therapies with extensive profiles of products that could enter the market over the forecast period, highlighting clinical performance, potential commercial positioning, and how they will compete with other therapies.

Predict breast cancer market growth in the five assessed Asia-Pacific markets, with epidemiological and annual cost of therapy forecasts across India, China, Australia, South Korea and Japan, as well as the individual contributions of promising late-stage molecules to market growth.

Thank you for your request.

One of our specialist advisors will be in contact with you shortly.

Terms & Conditions

GBI Research is a subsidiary of GlobalData Ltd ("Holding Company"), a company registered
in England with the company number 05968121 and registered office at John Carpenter
House, John Carpenter Street, London, EC4Y 0AN, United Kingdom. These terms and
conditions and the Order Form comprise the agreement pursuant to which Company provides
the Product (defined below) to you ("Agreement"). "We", "us", "our" or "GBI Research"
refers to Company. "You" or "your" refers to the person who (or on whose behalf)
an Order is placed and includes your legal successors and permitted assigns.

Order Forms: Order forms and confirmed online orders (either payable by credit card
or invoice) shall only be binding when accepted by us. You shall not cancel or amend
an order form or online order unless we have given our prior written consent. We
shall assume that any person who places an online order or compeltes an order form
on your behalf can bind you legally.

Ownership: The legal and beneficial interest in all copyrights, patents, trade marks,
service marks, design rights (whether registered or unregistered), database rights,
proprietary information rights and all other proprietary rights as may exist anywhere
in the world together with applications associated with any such rights ("Intellectual
Property Rights") relating to the Product belong to us, the holding company, or
our licensors, as the case may be, at all times. You obtain no ownership rights
in the Product or any of the Intellectual Property Rights pursuant to or arising
out of this Agreement.

Grant of License: We grant you a non exclusive, non transferable license to use
the products described in the order form or Report Store ("Product"). You warrant
that you shall only use the Product for your business purposes in accordance with
this agreement and shall not, without our prior written consent, make available,
copy, reproduce, retransmit, disseminate, sell, license, distribute, publish, broadcast
or otherwise circulate the Product (or any part of it) to any person other than
in accordance with these terms and conditions. You further warrant that you shall
comply with all applicable laws and regulations and shall not knowingly use the
Product for any improper or unlawful purposes.

License: Unless stated otherwise on the order form or specified via the online Report
Store, the Product is licensed to you on a single user basis. Only the user named
on the order form as the customer may use the product as outlined in this agreement.
Additional user licenses may be purchased by you at our prevailing standard list
prices for single users or by the purchase of a site wide or enterprise wide license.
You warrant that you will use appropriate controls to ensure that the license is
not breached by you or by other users and agree that any breach may cause us irrepreable
harm. You agree we have the right to charge additional fees for unauthorized usage
in line with our standard list prices. This clause survives termination of the Agreement.

Fees and Payment Terms: Payment is due in full prior to delivery of any product.
We shall invoice you for fees payable by you to us under this Agreement ("Fees")
upon our acceptance of an Order Form. Unless indicated otherwise on the order form
you will pay all invoices on receipt of that invoice. We may issue the invoice in
print and/or electronic form. Unless expressly provided the fees exclude any sales,
use, excise, or other applicable taxes. You will pay or reimburse us for any such
taxes for which either party may become held responsible for. A fee for late payment
will be assessed equal to the lower of one and one half percent (1.5%) per month
and the maximum permitted by law. In addition you agree that all sales are final
and that you may not request a refund. We reserve the right, for any reason whatsoever,
to withold delivery of the Product to you until payment has been received in full.

Warranties: We shall use best endeavors to ensure the Product is provided to you
in accordance with any specifications set out in the order form and accepted by
us. We do not warrant that the Product will meet your requirements or that it will
be complete, error free or delivered without interruption. Findings, conclusions
and recommendations in the Product are based on information gathered in good faith
from both primary and secondary sources, whose accuracy we are not always in a position
to guarantee. As such, we can accept no liability whatsoever for actions taken based
on any information that may subsequently prove to be incorrect. Except as expressly
set out in this Agreement, all express or implied representations, warranties, conditions
and undertakings are excluded to the maximum extent permissible by law. You assume
sole responsibility for the selection, suitability and use of the Product and acknowledge
that except as stated above we do not provide any additional warranties or guarantees
relating to the Product. This clause survives termination of the Agreement.

Indemnification. Generally. We and You (“Both Parties”) will, to the extent permitted
by law, indemnify, defend and hold harmless the other party from and against any
and all claims, demands, complaints, or actions of third parties (including employees
of the parties) arising from or relating to this agreement, including personal injury,
death and property damage to the extent caused or arising out of the violation of
law, gross negligence, fraud, willful misconduct or breach of this agreement. In
the event that both parties are at fault they will indemnify each other in proportion
to their relative negligence. In addition we will indemnify, defend and hold harmless,
you from and against any and all claims, demands, complaints or actions of third
parties (including employees of the parties) arising from or relating to this agreement
brought against you alleging that the product infringe any patent, copyright, trademark,
trade secret or other intellectual property right. Our obligations under this section
are conditioned on you i) Promptly notifying us of any claim, ii) Granting us sole
control over the defense and settlement of the action. iii) Reasonably cooperating
with us in connection with such action at our expense, iv) Abetting no such claim,
demand, complaint or action v) Neither modifying or using the product nor breaching
this agreement in a manner for which no infringement would have occurred. If the
product becomes or in our opinion is likely to become the subject of such a claim,
then in lieu of the indemnity we may, at our expense, i) procure you the right to
license using or receiving the product free of any such liability, ii) replace or
modify in whole or part the product to make them non-infringing without degradation
or iii) refund you a pro-rata portion of the fee.

Limitation of liability: Neither party shall be liable under this agreement to the
other party for indirect, special, exemplary, punitive or consequential damages
including without limitation loss of goodwill, whether arising from negligence,
breach of contract or otherwise. Our liability in contract, tort or otherwise arising
out of or in connection with the Agreement shall in respect of any one or more incidents
not exceed the total fees received by us from you for the Product in the 12 months
prior to the date the incident occurs. This clause shall survive termination of
the Agreement.

Confidentiality: Neither party shall, except as required to perform our and / or
your respective rights and obligations, use, copy, adapt, alter, disclose to any
third party or part with possession of any information or data of the other party
which is disclosed or otherwise comes into our or your possession directly or indirectly
as a result of these Terms and which is of a confidential nature, in writing marked
confidential or, if disclosed orally, reduced to writing and marked confidential
within 30 days of the date of such disclosure ("Information"). This obligation shall
not apply to Information:

the receiving party can prove was in its possession at the date it was received
or obtained; or

the receiving party obtains from some person other than us, you or an Affiliate
with good legal title thereto; or

comes into the public domain otherwise than through the default or negligence of
the receiving party; or

is independently developed by or for the receiving party.

Solicitation. You agree that for a period of twelve (12) months immediately following
the delivery of the products purchased, for any reason, whether with or without
cause, you shall not either directly or indirectly solicit, induce, recruit or encourage
any of the Company’s employees, who were involved in the sale, marketing, support
or production of the product used, to leave their employment, or attempt to solicit,
induce, recruit, encourage or take away employees of the Company.

Force Majeure: We shall not be liable for any delay or failure to perform any obligation
under this Agreement insofar as the performance of such obligation is prevented
by an event beyond our reasonable control, including but not limited to, earthquake,
fire, flood or any other natural disaster, labor dispute, riot, revolution, terrorism,
acts of restraint of government or regulatory authorities, failure of computer equipment
and failure or delay of sources from which data is obtained.

Further Provisions: The Agreement constitutes the entire understanding between the
parties relating to the Product and supersedes all previous agreements and understandings
whether oral or written relating to the Product. In the event of any inconsistency
between these terms and conditions and the Order, the Order shall prevail. The Agreement
may only be varied in writing signed by an authorized representative of each party.
Failure at any time to enforce any of these terms and conditions or to require performance
by the other party of any such term or condition shall not be construed as a waiver
of such provision or affect the right of either party to enforce the same. If any
provision is held to be invalid or unenforceable by any tribunal of competent jurisdiction,
the remaining provisions shall not be affected and shall be carried out as closely
as possible according to the original intent. The Agreement does not confer any
rights to or on any third party. The Agreement shall be governed by the laws of
England and Wales. The parties irrevocably agree to the exclusive jurisdiction of
the Courts of England.

Privacy Policy

At GBI Research we are dedicated to safeguarding and preserving your privacy when
visiting our site or communicating electronically with us.

This Privacy Policy, together with our terms of use, provides an explanation as
to what happens to any personal data that you provide to us, or that we collect
from you.

This Policy is updated from time to time so please review this Policy regularly.

For the purpose of the Data Protection Act 1998 our data controller is GBI Research.

GBI Research is subject to the UK Data Protection Act 1998 and is registered in
the UK with the Information Commissioner to process your personal information.

Information We Collect

In operating our website we may collect and process the following data about you:

Details of your visits to our website and the resources that you access, including,
but not limited to, traffic data, location data, weblogs, IP address, operating
system, access times, what browser you are using and other communication data.

A number of websites within our group of companies, subsidiaries, related companies
and affiliates are tracked using Google Analytics and WebTrends. To view their respective
privacy polices and details on opting out, please use the following links:

Information that you provide by filling in forms on our website, such as when you
register for information or make a purchase.

Information provided to us when you communicate with us for any reason.

Use of Cookies

On occasion, we may gather information about your computer for our services and
to provide statistical information regarding the use of our website to our advertisers.
Such information will not identify you personally it is statistical data about our
visitors and their use of our site. This statistical data does not identify any
personal details whatsoever.
Similarly to the above, we may gather information about your general internet use
by using a cookie file. Where used, these cookies are downloaded to your computer
automatically. This cookie file is stored on the hard drive of your computer as
cookies contain information that is transferred to your computer's hard drive. They
help us to improve our website and the service that we provide to you.
All computers have the ability to decline cookies. This can be done by activating
the setting on your browser which enables you to decline the cookies. Please note
that should you choose to decline cookies, you may be unable to access particular
parts of our website.
Our advertisers may also use cookies, over which we have no control. Such cookies
(if used) would be downloaded once you click on advertisements on our website.

Cookies we set on our own sites

These cookies include:

ASP.NET_SessionId and __RequestVerificationToken_Lw__ cookies. These cookies are
used to remember things during your session, so we can do things within the session
like logins and personalisation of settings. When you close your browser, these
cookies are deleted.
WT_FPC This is a WebTrends tracking cookie. We use this to track users anonymously
through the site.

Cookies set on our sites by our commercial service providers

We use a range of third party services on our sites, from statistics packages to
advertising, video delivery, content delivery and even low level, techie functions
like load balancing our servers so they are always available when you want to use
them. Some of these services require the use of cookies to work properly. These
services include:

Statistics

Google Analytics provide anonymised statistical information for us. They process
IP addresses and information from other cookies used on our sites so we know how
many page views we have, how many users we have, what browsers they are using (so
we can target our resources in the right way to maximise compatibility for the majority
of our users) and, in some cases, in which country, city or region they are located.
These cookies include: __gads, __utma, __utmb, __utmc and __utmz

Google Analytics Privacy Policy

Social Media Tracking

__utmx, __utmxx, di, dt, loc, psc, uid, uit and uvc are cookies that are used to
collect certain non-personally identifiable information automatically for use on
the ÒAddThis PlatformÓ. This enables us to better understand how people are consuming
and sharing our content socially and which content is more popular.

AddThis.com Privacy Policy

Third Party Links

The advertisements on our sites are served by a number of third party ad serving
providers, including DoubleClick, Advertising.com, Adviva.net (Specific Media),
AdRevolver (BlueLithium-Yahoo!), 247realmedia.com and Eyeblaster, amongst others.
The cookies accompanying the ads allow them and their advertisers to monitor the
effectiveness of the ads (e.g. by using statistical analysis cookies) and make the
ads more relevant to you (e.g. if you use our sites from outside of the UK, you
may get ads from your local country). If you would like more information about the
cookies used by the providers listed above, please see their privacy policies at:

General third party opt-outs

You can learn about and opt out of a number of commercial third party cookies at
www.networkadvertising.org/managing/opt_out.asp Some of
the opt-outs used by our commercial service providers require a cookie to be placed
on your PC which is only used to tell the relevant cookie servers not to send you
any further cookies.

SETTING UP YOUR BROWSER TO CONTROL OR DELETE COOKIES

You can find up-to-date information clearly explaining how to control or delete
cookies on your Windows PC or Apple Mac at www.aboutcookies.org

To control or delete cookies on your mobile phone, please refer to your handset
manufacturer's help manual.

We use Macromedia Flash Player to deliver certain services on our sites. To improve
user experience, Local Shared Objects - or Flash Cookies as they are commonly known
- are employed to provide features such as auto-resume or saving preferences. Flash
Cookies are stored on a user's terminal much the same as cookies are, however it
is not possible to manage them at browser level in the same way.

The Adobe website provides comprehensive information on how to delete or disable
Flash cookies either for a specific domain or for all websites - see http://kb2.adobe.com/cps/526/52697ee8.html
for details. Please be aware that restricting the use of Flash Cookies may affect
the features available to you for Flash-based applications on our sites.

Further information

Use of Your Information

The information that we collect and store relating to you is primarily used to enable
us to provide our services to you. In addition, we may use the information for the
following purposes:

To provide you with information requested from us, relating to our products or services.
To provide information on other products or services within our group of companies,
subsidiaries, related companies and affiliates, which we feel may be of interest
to you.

To meet our contractual commitments to you.

To notify you about any changes to our website, such as improvements or service/product
changes, that may affect our service.

Personalise your experience.

If you are a previous or existing customer, we may contact you with information
about products and services similar to those which were the subject of a previous
sale to you.
Furthermore, we may use your data, or permit selected third parties to use your
data, so that you can be provided with information about unrelated products and
services which we consider may be of interest to you. We or they may contact you
about these products and services by any methods that you consented at the time
your information was collected.
You may stop these messages at any time by emailing clientservices@gbiresearch.com or opting-out using the opt-out
tool at the bottom of the email communication.

Information About Other People

On certain parts of the website, you can submit information about other people.
For example, you may be able to provide an email address of colleagues who may be
interested in registering to attend an event. We will use this information to contact
these people for the purposes of increasing event attendance.

These messages can be stopped at any time by emailing clientservices@gbiresearch.com or opting-out using the opt-out
tool at the bottom of the email communication.

Chat and Message Boards

A number of websites within our group of companies, subsidiaries, related companies
and affiliates offer chat and message boards. Please be advised that information
posted in these venues may become public knowledge.

Storing Your Personal Data

We may transfer data that we collect from you to locations outside of the European
Economic Area for processing and storing. Also, it may be processed by staff operating
outside the European Economic Area who work for us or for one of our suppliers.
For example, such staff maybe engaged in the processing and concluding of your order,
the processing of your payment details and the provision of support services. By
submitting your personal data, you agree to this transfer, storing or processing.
We will take all reasonable steps to make sure that your data is treated securely
and in agreement with this Privacy Policy.
Data that is provided to us is stored on our secure servers. Details relating to
any transactions entered into on our site will be encrypted to ensure its safety.
The transmission of information via the internet is not completely secure and therefore
we cannot guarantee the security of data sent to us electronically and transmission
of such data is therefore entirely at your own risk. Where we have given you (or
where you have chosen) a password so that you can access certain parts of our site,
you are responsible for keeping this password confidential.

Disclosing Your Information

Where applicable, we may disclose your personal and non-personal information to
any member of our group. This includes, where applicable, subsidiaries, related
companies or affiliates.
We may also disclose your personal and non-personal information to third parties:

Where we sell any or all of our business and/or our assets to a third party.

Where we are legally required to disclose your information.

To assist fraud protection and minimise credit risk.

Children

Please note that we do not collect any personal information from children under
thirteen years of age and that no child under thirteen should submit any personal
information to any of the Sites. Should we discover that any such personal information
has been delivered to any of the Sites, we will remove that information as soon
as possible.

Access To Information

The Data Protection Act 1998 gives you the right to access the information that
we hold about you. Please note that any demand for access may be subject to payment
of a fee of £10 which covers our costs in providing you with the information requested.
Should you wish to receive details that we hold about you please contact us using
the contact details below.

Contacting Us

We welcome any queries, comments or requests you may have regarding this Privacy
Policy. Please do not hesitate to contact us at:

Terms & Conditions

The Copyright in all of the Copyright works contained within these pages is either
owned by GBI Research or licensed to it. Reproduction of part or all of the contents
of any of these pages is prohibited except to the extent permitted below.

These pages and the separate Copyright works contained therein may be viewed on
screen, downloaded onto a hard disk or printed for your personal use provided that
you include this Copyright notice on each copy and that you make no alterations
to any of the pages and do not use any of the pages in any other work or publication
in whatever medium stored. Copyright works contained in these pages may not be used,
distributed or copied for any commercial purpose.

Without prejudice to the limited Copyright licence granted above and solely to the
extent that all or parts of these pages constitute a "database" for the purposes
of the Copyright and Rights in Databases Regulations 1997 ("the Regulations") reproduction
of part or all of these pages is prohibited to the fullest extent permitted by the
Regulations.

Legal Disclaimer

Please read this section carefully as it contains the legal terms and conditions
that you agree to when you use our Site.

The Operator

This website is operated by GBI Research, a subsidiary of GlobalData Ltd, Limited
Registered Office: John Carpenter House, John Carpenter Street, London EC4Y 0AN,
UK. Registered in England No. 05968121

Definitions

References to "we" or "us" in these Terms and conditions are to gbiresearch.com

References to "you" in these Terms and conditions are to the users of this website.

References to "Partner Organisation" in these Terms and conditions are to organisations
with whom gbiresearch.com has complied
this website.

References to "the site" in these Terms and conditions are to this website and its
contents.

Terms and Conditions

The information on this Site has been included in good faith for general informational
purposes only. The Site may contain information submitted by a third party including
adverts. The information should not be relied upon for any specific purpose and
no representation or warranty is given as to its accuracy or completeness.

Any opinions (express or implied) are those of the individual authors and not necessarily
those of GBI Research or its partner organisations.

Except for any express warranties or undertakings given on the Site, we exclude
all warranties (express or implied) in respect of the Site and the content of and
your use of the Site.

We shall not be liable to you for any loss that you suffer (including, without limitation,
damages for any consequential loss or loss of business opportunities or projects,
or loss of profits) howsoever arising, whether in contract, tort or otherwise from
your use or inability to use this Site, or any of its contents, or from any action
or omission taken as a result of using this Site provided that nothing in these
terms shall exclude or limit our liability for personal injury or death caused by
our negligence.

We may provide links to other websites from time to time. These links are provided
for your convenience. We do not endorse or take responsibility for the content of
those websites, we are not responsible for the availability of them and will not
be liable in any way for any loss or damage which you may suffer by your use or
inability to use those websites.

If you decide to access linked websites you do so at your own risk. If you purchase
any goods or services from a third party or third party website to which we provide
a link your contract for the supply of those goods and services will be with that
third party.

Reference to any product or service on the Site does not constitute an offer to
sell or supply that product or service and does not mean that the product or service
is available in all countries or that the name and description of any product in
your country will be the same as that included on the Site.

We have taken every care in the preparation of the Site. However, as certain technical
matters may be beyond our control, we cannot guarantee that you will have uninterrupted
or error-free access to the Site at all times.

By submitting personal information via any of the online forms on the site, you
consent to being contacted (either by phone or email) by a GBI Research representative.

We make no warranty that the contents of the Site are free from infection by viruses
or anything else which has contaminating or destructive properties and shall have
no liability in respect thereof.

We reserve the right at any time, without liability for doing so, to modify or discontinue,
temporarily or permanently, any of the content, functions or services we offer on
the Site (or any part of them) with or without notice. This includes removing information
transmitted by you to us.

You agree that the information you provide us with when you use the Site will be
true and complete and that you will keep it true and complete.

Transmit any material that contains software viruses or any other computer code,
files or programs designed to interrupt, damage, destroy or limit the functionality
of any computer software or hardware or telecommunications equipment;

Interfere with or disrupt the services or servers or networks connected to the services,
or disobey any requirements, procedures, policies or regulations of networks connected
to the services; or collect or store personal data about other users.

Amendment of the Terms and conditions

We reserve the right to amend these Terms without notice to you from time to time.
Any such amendment shall be effective once the revised terms have been posted on
the Site.

Applicable Law

We reserve the right to amend these Terms without notice to you from time to time.
Any such amendment shall be effective once the revised terms have been posted on
the Site.